goat antihuman lepr (Bio-Rad)
Structured Review
![Figure 3. Tamoxifen significantly <t>decreased</t> <t>leptin</t> and increased adiponectin in normal human breast tissue. A. Postmenopausal women underwent microdialysis sampling of breast tissue (n 18) and subcutaneous (sc) abdominal fat (n 16) before tamoxifen treatment and 6 weeks after treatment. *P .05, **P .01. B. To confirm the in vivo findings, whole normal human breast tissue biopsies were cultured with or without 10-6 M tamoxifen (Tam) for 7 days, and adipokine levels in the culture medium were determined. *P .05 (n 9), ****P .0001 (n 12) compared to controls. C. Normal breast tissue biopsies were cultured ex vivo with or without 10-6 M tamoxifen (Tam). Levels of adipokines and their corresponding receptors (leptin receptor <t>[LepR],</t> adiponectin receptor 1 [AdipoR1], and adiponectin receptor 2 [AdipoR2]) were determined by immunohistochemistry analysis. No differences were detected between treatment groups. Representative tissue sections from each treatment group are shown (scale bars, 20 m).](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_6929/pm24796929/pm24796929__page7_image1.jpg)
Goat Antihuman Lepr, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat antihuman lepr/product/Bio-Rad
Average 90 stars, based on 2 article reviews
Images
1) Product Images from "Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo."
Article Title: Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo.
Journal: The Journal of clinical endocrinology and metabolism
doi: 10.1210/jc.2014-1129
Figure Legend Snippet: Figure 3. Tamoxifen significantly decreased leptin and increased adiponectin in normal human breast tissue. A. Postmenopausal women underwent microdialysis sampling of breast tissue (n 18) and subcutaneous (sc) abdominal fat (n 16) before tamoxifen treatment and 6 weeks after treatment. *P .05, **P .01. B. To confirm the in vivo findings, whole normal human breast tissue biopsies were cultured with or without 10-6 M tamoxifen (Tam) for 7 days, and adipokine levels in the culture medium were determined. *P .05 (n 9), ****P .0001 (n 12) compared to controls. C. Normal breast tissue biopsies were cultured ex vivo with or without 10-6 M tamoxifen (Tam). Levels of adipokines and their corresponding receptors (leptin receptor [LepR], adiponectin receptor 1 [AdipoR1], and adiponectin receptor 2 [AdipoR2]) were determined by immunohistochemistry analysis. No differences were detected between treatment groups. Representative tissue sections from each treatment group are shown (scale bars, 20 m).
Techniques Used: Sampling, In Vivo, Cell Culture, Ex Vivo, Immunohistochemistry
Figure Legend Snippet: Figure 4. Increased extracellular leptin and decreased adiponectin in human breast cancer in vivo. A. Eleven postmenopausal breast cancer patients underwent microdialysis sampling of the tumor and normal adjacent breast tissue before surgery. *P .05, **P .01. B. FVB/N mice were oophorectomized and treated with or without estradiol (physiologic level), and MMTV- PyMT mammary cancer cells were injected into the dorsal mammary fat pad. At similar tumor sizes, both groups of mice underwent microdialysis sampling of adipokines in the tumor. *P .05, **P .01 (each group, n 7). C. FVB/N mice were treated as described in Figure 4B. Levels of adipokines and their corresponding receptors (leptin receptor [LepR], adiponectin receptor 1 [AdipoR1], and adiponectin receptor 2 [AdipoR2]) in the MMTV-PyMT tumors were determined by immunohistochemistry analysis. Increased LepR staining was observed in estrogen-exposed tumors. Representative tissue sections from each treatment group are shown (scale bars, 20 m).
Techniques Used: In Vivo, Sampling, Injection, Immunohistochemistry, Staining